KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.87 $1.65 Friday, 26th Apr 2024 ADAP stock ended at $1.08. This is 1.42% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.83% from a day low at $1.03 to a day high of $1.09.
90 days $0.730 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
May 03, 2021 $5.70 $5.80 $5.45 $5.68 491 097
Apr 30, 2021 $5.84 $5.97 $5.65 $5.66 723 825
Apr 29, 2021 $5.78 $5.93 $5.61 $5.78 541 093
Apr 28, 2021 $5.67 $5.78 $5.56 $5.74 1 210 894
Apr 27, 2021 $5.65 $5.80 $5.51 $5.64 1 207 180
Apr 26, 2021 $5.44 $5.81 $5.41 $5.63 1 064 203
Apr 23, 2021 $5.11 $5.50 $5.03 $5.43 723 065
Apr 22, 2021 $4.89 $5.28 $4.72 $5.08 929 708
Apr 21, 2021 $4.71 $4.94 $4.60 $4.88 422 296
Apr 20, 2021 $4.65 $4.81 $4.60 $4.72 450 567
Apr 19, 2021 $4.90 $5.01 $4.61 $4.68 1 136 883
Apr 16, 2021 $5.03 $5.03 $4.81 $4.93 756 820
Apr 15, 2021 $5.17 $5.21 $4.93 $5.04 329 708
Apr 14, 2021 $5.11 $5.32 $5.03 $5.04 484 907
Apr 13, 2021 $4.95 $5.08 $4.89 $5.07 391 401
Apr 12, 2021 $5.05 $5.11 $4.87 $4.97 425 397
Apr 09, 2021 $5.08 $5.39 $4.92 $5.05 938 941
Apr 08, 2021 $5.05 $5.18 $5.03 $5.13 384 936
Apr 07, 2021 $5.23 $5.25 $4.87 $4.97 1 251 778
Apr 06, 2021 $5.64 $5.64 $5.11 $5.27 519 876
Apr 05, 2021 $5.63 $5.77 $5.44 $5.61 518 670
Apr 01, 2021 $5.36 $5.86 $5.32 $5.50 907 241
Mar 31, 2021 $5.12 $5.52 $5.09 $5.31 773 439
Mar 30, 2021 $4.90 $5.13 $4.80 $5.05 485 219
Mar 29, 2021 $5.08 $5.19 $4.90 $4.94 1 144 277
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT